Allworth Financial LP Reduces Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Allworth Financial LP decreased its holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 22.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,430 shares of the company’s stock after selling 423 shares during the period. Allworth Financial LP’s holdings in iShares U.S. Pharmaceuticals ETF were worth $95,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Pallas Capital Advisors LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at about $3,829,000. Strategic Financial Concepts LLC purchased a new position in iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at approximately $1,312,000. Grimes & Company Inc. bought a new stake in iShares U.S. Pharmaceuticals ETF during the 4th quarter worth approximately $967,000. Flow Traders U.S. LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF in the 3rd quarter worth approximately $839,000. Finally, Thrivent Financial for Lutherans boosted its holdings in iShares U.S. Pharmaceuticals ETF by 23.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 32,509 shares of the company’s stock valued at $2,295,000 after purchasing an additional 6,214 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Performance

iShares U.S. Pharmaceuticals ETF stock opened at $72.01 on Tuesday. iShares U.S. Pharmaceuticals ETF has a fifty-two week low of $62.67 and a fifty-two week high of $72.94. The stock has a market cap of $727.30 million, a P/E ratio of 6.49 and a beta of 0.58. The firm’s fifty day moving average price is $67.90 and its 200-day moving average price is $69.30.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.